MentionFox
Home › funding signals › Dosentrx Ltd.
Form D · on the record

Dosentrx Ltd. — $1.78M Form D filing, March 2026

Dosentrx Ltd. filed a Form D with the Securities and Exchange Commission on 2026-03-19.

Dosentrx Ltd. filed a Form D notice of an exempt securities offering with the SEC on March 19, 2026. The filing reports $1.78M sold. Its industry group is Pharmaceuticals. It names Mark Summers (Executive Officer), Jon Roberts (Director), Daniel Beck (Director) (SEC Form D, March 19, 2026).

Sell to companies like Dosentrx Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

88 companies raised this week, 1 had other signals.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

fal - Features & Labels, Inc.$1BAI and software
fal - Features & Labels, Inc.$350MAI and software
SIERRA INTERNATIONAL NETWORK INC$300MAI and software
Zai Lab Ltd$250MBiotech
Databento Inc.$100MAI and software
Check one company free All companies that raised this week

5 more Pharmaceuticals raises within 90 days of this one ↓

Is this your company?

Key facts

Run the free check on Dosentrx Ltd. →

Dosentrx Ltd.

New Form D on file · 2026-03-19 · the record

$1.78M
raise on the record
D
filing
17
investors in
ISRAEL
based
Open the record →

What the record says

FilingForm D
Filed2026-03-19
Industry groupPharmaceuticals
Entity typeCorporation
Incorporated inISRAEL
BasedMODIIN MACCABIM REUT, ISRAEL
CIK2121365
Accession0002121365-26-000001

Pitching, partnering or investing alongside them? See who really runs and owns Dosentrx Ltd.

Free to see. No signup.

Keep reading

More on the people and the money behind Dosentrx Ltd., from the filings we hold.

Raised through the same sales agent

Cedar Point Capital LLC received sales compensation on this raise and on 8 other raises we hold, nearest in date first:

More raises like this

Pharmaceuticals raises filed within 90 days of this one, largest first.

What do you want to do with Dosentrx Ltd.?

Get the full cited report on Dosentrx Ltd.

What the filing shows about Dosentrx Ltd.

  • 17 investors had already put money in when it filed.
  • The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Dosentrx Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look Dosentrx Ltd. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Dosentrx Ltd.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives Dosentrx Ltd.'s address as 1 Hamaayan St, Modiin Maccabim Reut, L3 7177874.

What the filing says

  • Offered: $6,000,000. Sold: $1,780,000. Left to sell: $4,220,000. (filing)
  • Investors: 17 had already invested. (filing)
  • Date of first sale: February 18, 2026. (filing)
  • Types of securities: Equity; Securities to be acquired on exercise of an option, warrant or other right. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Dosentrx Ltd. See pricing

Is Dosentrx Ltd. a real, registered company?

Dosentrx Ltd. is a registered filer with the SEC (CIK 2121365) and has filed since 2026-03-19. 1 filing is on record, the latest on 2026-03-19.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Dosentrx Ltd.?

Dosentrx Ltd.'s Form D of 2026-03-19 names Mark Summers, Jon Roberts, Daniel Beck and 4 more as its officers, directors or promoters.

How much has Dosentrx Ltd. raised?

Its new offerings report $1.78M sold across 1 offering, as its own filings state.

Pharmaceuticals · by week
This raise, $1.78M, filed week of Mar 16

Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $1.78M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Dosentrx Ltd.?

What the filing shows about Dosentrx Ltd.

  • 17 investors had already put money in when it filed.
  • The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Dosentrx Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Dosentrx Ltd. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Dosentrx Ltd.. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Dosentrx Ltd.: Raised $1.78M, Form D filed 2026-03-19
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/dosentrx-ltd-form-d-26000001
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
Dosentrx Ltd. raised $1.78M — SEC Form D filing, March 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/dosentrx-ltd-form-d-26000001